Psilocybin (Magic Mushrooms): FAQs, Benefits & Risks

What is Psilocybin?

ask people who ’ ve tried alleged “ charming mushrooms ” what the know was like, and many will tell you it ’ second life-changing. Turns out, those aren ’ thyroxine good the ravings of a hallucinogenic mind. In fact, a growing group of researchers is excited about the likely benefits of psilocybin, the primary coil hallucinogenic colonial in ’ shrooms, which is showing a lot of promise for helping people overcome hard-to-treat ( or treatment-resistant ) and life-disrupting conditions like addiction and major depression .
yet since 1970, psilocybin has been classified as a Schedule 1 illicit drug, which is defined as having no presently accepted medical manipulation in the US, angstrom well as a high likely for abuse. so, why the recent revival in psilocybin concern, and what is the research showing in terms of benefits, mechanism of action, and even safety ? hera ’ s the lowdown, but first, a history lesson :

’Shrooms: A Long Strange Trip Through Time

Magic mushrooms have been used for more than 10,000 years in diverse spiritual and medical rituals for their ability to alter awareness and trigger mystic experiences .
As the report goes, R. Gordon Wasson, an american banker, and mushroom enthusiast was vacationing with his wife in Mexico in 1955 when they became the foremost outsiders to participate in the Mazatec Indians ’ consecrated mushroom rituals with a therapist named Maria Sabina. He brought some of the mushrooms back to his home in New York City, and by and by shared his experience in Mexico in a Life magazine article published in 1957, when LSD—a chemically-similar psychedelic but about 1000 times more potent—was already being studied for its ability to treat dipsomania and early psychiatric illnesses. ( A 25 milligram acid of psilocybin is equivalent to approximately 250 micrograms of LSD. )

Three years late, two Harvard psychologists—Timothy Leary and Richard Alpert—began to explore how cognition, sensing, and emotion are impacted by psychedelic drugs. They started the ill-famed Harvard Psilocybin Project, which involved administering psilocybin to student volunteers to document its effects. Bear in heed, psilocybin and LSD were legal then, but both Leary and Alpert were besides tripping during their experiments, which ultimately got them fired in 1963 .
article continues below

Do you feel depressed?

Take one of our 2-minute Depression quizzes to see if you or a loved one could benefit from far diagnosis and treatment . Take Depression Quiz Take Partner Depression Quiz By now, psychedelics were gaining a reputation in mainstream acculturation as being dangerous. numerous states began banning their habit, and in 1970, Congress passed the Controlled Substances Act and classified both psilocybin and LSD as Schedule 1 drugs. With both now illegal, funds for research on psychedelics disappeared and research slowed to a dribble .
But it didn ’ triiodothyronine barricade all in all, and decades of findings lento accumulated, showing the benefits of psilocybin. In 2018, the FDA took notice of studies looking at its ability to ease treatment-resistant depressive disorder, and designated it as a Breakthrough Therapy, a classification that indicates significant curative likely, and fast-tracked the development and review procedure .
Another sign of its electric potential as a clinical discussion : Johns Hopkins University launched the Center for Psychedelic & Consciousness Research in September 2019, where research continues to reveal psilocybin ’ mho therapeutic effects. A small handful of other, reputable centers for psychedelic research have besides cropped up including the Center for Neuroscience of Psychedelics at Massachusetts General Hospital and the Imperial Psychedelic Research Programme at Imperial College London .

What the Research on Psilocybin Therapy Shows

What ’ s most matter to about psilocybin is its ability to address a few different types of conditions. “ The most predict likely is for addiction —smoking, dipsomania, cocaine, ” says Matthew W. Johnson, PhD, a professor of psychiatry at Johns Hopkins University and consociate director of the Center for Psychedelic & Consciousness Research. His ongoing pilot program report on nicotine addiction has found that 80 % of participants who underwent psilocybin therapy depart smoke, and 60 % of them were still abstinent 16 months later—impressive compared to the 35 % achiever rate of varenicline, the most effective of other smoking cessation therapies. “ The idea that something could be effective for multiple substances is, itself, identical atypical and exciting, ” says Johnson. “ There ’ s a very good character that psilocybin can treat the psychology of addiction, not equitable alleviate the withdrawal symptoms and reduce cravings. ”
In addition to treating addiction, psilocybin has besides shown impressive results in treating depressio n and end anxiety. For example, one belittled recent study published in JAMA Psychiatry found that patients with major depressive perturb experienced significant improvement after being treated with psilocybin in combination with psychotherapy, and more than half were in remission four weeks subsequently. “ The most promote study is with patients with dangerous cancer, where we saw dramatic reductions in natural depression and anxiety that showed haunting benefits six months subsequently, which is highly atypical, ” says Dr. Johnson .
Beyond those applications, researchers are besides looking at psilocybin for anorexia, Alzheimer ’ second ( related to both low and cognitive worsen ), post-traumatic stress disorder, demoralization syndrome ( suffering characterized by feelings of hopelessness and loss of purpose/meaning in life ) experienced by long-run HIV survivors, and obsessive-compulsive disorderliness. “ We don ’ t have the answers yet, but I would say they ’ ra good bets, ” says Johnson .

How Psilocybin Works Its “Magic” in the Brain

precisely what psilocybin does to the brain to trigger changes in climate and behavior is distillery a large mystery, but we know that, acutely, when person ’ randomness on a psychedelic drug, the brain communicates in a much different way than it was “ programmed ” to, says Michael McGee, MD, staff psychiatrist at Atascadero State Hospital in California and generator of The Joy of Recovery. He explains that the program begins in mid to late childhood to handle the roughly 90 to 100 billion neurons in the cerebral cortex, the outermost layer of the brain that plays a key character in higher-order functions such as perception, thought, memory, and judgment. “ If all of those neurons could communicate with each other, the act of likely connections is probably higher than the issue of atoms in the universe, ” says Dr. McGee .
But the brain can ’ thymine function like that—it has to be efficient for its survival. “ so there ’ sulfur a pruning procedure, where perceptions of the manner we understand ourselves in the global are narrowed, and the ego-consciousness develops, ” explains Dr. McGee. “ And what happens to all of those nervous connections is that some get prioritized and are very effective, like highways with a batch of neural traffic going through, and the others are paired down and rarely used, like soil roads. ” That ’ s where psilocybin can come into play—it can basically open up those dirt roads again and send a batch more traffic down them .
“ Psilocybin and other psychedelics that are serotonin HT2A receptor agonists or stimulators massively increase mind randomness, so you have all of the neurons talking to each other in a very open, non-focused, and less organized way, ” Dr. McGee says. At the same clock time, he says, there ’ s a reduction of bodily process in the Default Mode Network ( DMN ), a network of interacting brain regions that ’ second active when you ’ re not focused on the external global. In early words, an inhibit DMN means there ’ s less of that stream of self-reflective think going on that we associate with our independent thinking self .
“ When that goes away, and it ’ s combined with all of these novel neural connections, the brain is capable of making radically different associations and developing new understandings of reality, ” says Dr. McGee. For example, if the manoeuver substitution class of the brain is trauma-based and defines others and the worldly concern as “ bad ” and “ insecure, ” it could be replaced with a larger prototype of “ good ” ( or at least a less inflexible have of negativity ) that sees the perfume of the population as love, and frankincense produces more feelings of sleep together and compassion .
Animal studies besides suggest that psychedelic drugs, like ketamine, can prompt the growth of newfangled neurons and branch between dendrites, the parts of brain cells that reach out and communicate with other brain cells, Johnson says “ It could be that these types of changes are unfolding in the days and weeks following a psilocybin seance, and they represent a kind of fluidity and malleability in the system, ” he explains. “ It ’ s like a fictile that ’ sulfur been heated and becomes ductile enough to reshape. finally, it ’ sulfur going to cool down, but you ’ ve established a new normal during this time. ”
big painting, Johnson suspects that the drug is augmenting the action of how people change their behavior by increasing their sense of receptiveness, which could lead to a future world with less depression, anxiety, and addiction. “ In all of the disorders we ’ re perusal, you ’ re basically talking about people who are stuck in a very narrow mental and behavioral repertory, and it ’ s very intemperate to get out once you ’ re there, ” says Johnson. “ There are thus many self-reinforcing properties—more negative think leads to less social interaction and then more focus on the addictive substance—and it ’ s that ‘ stuckness ’ that actually seems to be affected by psychedelic experiences. They seem to supply clearness and mental flexibility that allows people to jump outside their patterns. ”

What Happens During a Psilocybin Therapy Session?

Let ’ s beginning with the fact that psilocybin is silent illegal in all states except Oregon, which in November 2020 became the first state to permit regulated use in a remedy set only—it doesn ’ t have the same legal status as cannabis. ( note : While psilocybin may be legal in Oregon, it remains illegal on a federal horizontal surface. ) If you don ’ t live in Oregon or have access to a accredited facilitator and you ’ rhenium interested in trying psilocybin, there are a numeral of research trials in assorted phases that are recruiting both healthy participants and those with specific mental health conditions. ( To learn more, check out “ How to Join a Psychedelic Clinical Trial, ” below. )

As with all clinical trials, not everyone is qualified to participate. Volunteers are first cautiously screened to ensure they ’ ra not at hazard of an adverse reaction because psilocybin can exacerbate or trigger the attack of implicit in psychotic conditions. This means people with a personal or class history of conditions like schizophrenia are at high hazard of durable damage and should steer clear of psilocybin .
If selected, a player is set up in a control environment with a comfortable target to lie down with an eye mask and some happy music. “ Soothing music has been part of the psilocybin research protocols for decades, ” says Dr. McGee. “ I ’ m not sure of any attest that it ’ sulfur necessary for change, but intuitively it seems that it would help facilitate the experience. ” ( For more data on the role of music in psychedelic psychotherapy, see the work of Mendel Kaelen, PhD. )
then they ’ re given a controlled acid of synthetic psilocybin ; Johnson says 20 magnesium to 30 mg, adjusted to body weight, is used to bring on the mysterious experience .
Throughout the 6- to 8-hour seance, at least one train therapist with a chief ’ second academic degree ( or higher ) in clinical research stays with the participant at all times. The role of the train therapist is to maintain safety, reassure the participant when anxiety arises, and witness the procedure. Participants are encouraged to direct their attention inward and focus on changing insalubrious behaviors or healing afflictive emotions. This part—what Johnson calls “ consolidation ” —is critical .
“ You need to talk with the patient about what the experience means for their life. And if they ’ re prompted to make changes, discuss how they ’ re going to establish those changes in their life, ” he says. “ The genius is in a changeable state, and what you do during that time of malleability, and in the several follow-up sessions ( it can take one to three sessions, or more, to make a difference ), is what determines the real-world consequence. ”
Dr. McGee likens the integration serve to burning gasoline in a car. “ If you channel it through an engine, a gallon of gasoline could take you 30 miles. But if you just burn that gallon of accelerator in a pail, you won ’ deoxythymidine monophosphate get anything out of it. These psychedelic experiences are kind of like that : They need to be channeled through an integrative process where a new narrative and a new repertory of life skills is created and revised, equitable as happens in any kind of good therapy. ”

Psilocybin Risks: Important Things to Know

Despite its Schedule 1 status, psilocybin appears to have only mild addiction potentia l. “ It doesn ’ thymine act in the lapp manner on the advantage center of the genius or gun trigger compulsive consumption the manner addictive substances do, ” says Johnson. His research, published in Neuropharmacology, suggested that it be scheduled as a Schedule 4 means, which is comparable in the addictive likely to benzodiazepines. But, he stresses, psilocybin can absolutely be abused. “ There are cases of teenagers driving on it, or people falling from heights or stepping into traffic. It ’ s a mighty instrument that, if used in a dangerous way, could harm the person or the people around them. ”
What ’ s more, anyone can have a negative, emotionally painful, or frightening experience while on psilocybin, which again stresses the importance of a therapist and the consolidative procedure. “ Pain is not negative—you can have an inordinately painful have that turns out to be the most incontrovertible experience of your life, ” says Dr. McGee. “ That ’ s why you need to be organize ahead, and coached to lean into the have and accept it, not resist it. You ’ ve got to feel it to heal it. ”
Dr. McGee besides notes that most people who use psilocybin repeatedly experience tachyphylaxis, a quickly diminishing answer to consecutive doses of a drug, which renders it less effective. “ The effect is coarse with recur function of drugs that act on the anxious system, ” he explains .
ultimately, chronic use of psilocybin does come with cardiovascular risks. “ It binds to HT2B receptors, which can cause dangerous changes in the structure and determine of heart valves, ” Johnson says. Fen-phen—another drug that binds to HT2B receptors—was pulled from the market due to the risk of valvular affection disease, one induce of heart bankruptcy. “ This likely international relations and security network ’ t an write out at all when you ’ re taking the drug once or a few times for therapeutic impression, ” says Johnson. “ But when you start talking about taking it once every three or four days for years on end, that ’ s a major topic that people aren ’ thyroxine talking about enough. ”

How to Join a Psychedelic Clinical Trial

If you ’ rhenium interested in becoming a psychedelic lab denounce, there are a number of research trials in respective phases recruiting both healthy volunteers and those with specific mental health conditions. hera ’ s a list of inquiry institutes with ongoing or future trials you can explore for possible engagement .

• Johns Hopkins Center for Psychedelic and Consciousness Research. Visit hopkinspsychedelic.org/index/#research. Research focuses: smoking cessation, depression, Alzheimer’s disease, anorexia, co-occurring alcohol use disorder, and depression
• Usona Institute. Visit usonaclinicaltrials.org/major-depressive-disorder-psilocybin-clinical-trial-psil201. Research focus: depression
• Heffter Research Institute. Visit heffter.org/future-research/ to learn more about the psychedelic research they fund.
• Center for Neuroscience of Psychedelics at Massachusetts General Hospital. Visit rally.partners.org/. Research focus: nothing at this time
• Compass Pathways. Visit compasspathways.com/our-research/psilocybin-therapy/our-clinical-trials/treatment-resistant-depression/.  Focus: treatment-resistant depression
• Imperial Psychedelic Research Programme, Imperial College London. If you’re a resident of the UK, visit imperial.ac.uk/psychedelic-research-centre/trials/. Focus: major depression

Psilocybin FAQs

*Answers provided by Michael McGee, MD and Andrew Penn, NP

What does it feel like to take psilocybin?

Psilocybin, the basal hallucinogenic compound in charming mushrooms is a psychedelic drug that ’ second been used for more than 10,000 years in versatile religious and checkup rituals. Experiences can vary, but people report altered perceptions of meter and distance, feelings of euphoria, and a contemplative, dream-like express. Researchers frequently measure what they call the “ mystic feel ” according to a scale like the Hood Mysticism Scale, which quantifies a sense of oneness, sacredness, convinced temper, the transcendence of time/space, and more. “ The research shows that the more acute your mystic experiences, the more probably you ‘re going to experience positive benefits from the know, ” says Dr. McGee .

Does psilocybin have health benefits?

Researchers believe psilocybin has the potential to help curb addiction to nicotine, alcohol, cocaine, and possibly opioids. One little discipline ( of just nine participants ) on nicotine addiction found that 80 % of participants who underwent psilocybin therapy depart smoke, and 60 % of them were even abstinent 16 months later, impressive compared to the 35 % or less success rate of early therapies. Before being touted as a cure for cigarette smoke however larger studies would need to be conducted. In addition to treating addiction, psilocybin has besides shown impressive results in treating natural depression and death anxiety .

How can psilocybin help with addiction and depression?

Researchers suspect that the drug is augmenting the process of how people change their behavior by increasing their sense of receptiveness. In conditions like depression, addiction, or anxiety, people are stuck in a very pin down genial and behavioral radiation pattern that ’ mho hard to break. There are so many self-reinforcing properties—more veto think leads to less sociable interaction and then more focus on the addictive substance—and it ’ mho that ‘ stuckness ’ that very seems to be affected by psychedelic experiences. Psilocybin seems to empower a mental flexibility that, when paired with therapy and the right life skills, allows people to jump outside their patterns and establish healthier fresh ones .

Are there risks to taking psilocybin?

Because psilocybin can exacerbate or trigger the attack of underlie psychotic conditions, people with a personal or family history of conditions like schizophrenia are at high risk of durable injury and should steer clear of psilocybin. If not used in a manipulate environment with a mental health professional introduce, psilocybin is a knock-down tool that, if used in a dangerous way, could harm the person or the people around them. finally, chronic function of psilocybin does come with cardiovascular risks. It binds to HT2B receptors, which can cause dangerous changes in the structure and shape of heart valves. ( Fen-phen—another drug that binds to HT2B receptors—was pulled from the market due to risk of valvular heart disease, one causal agent of heart failure. ) Experts believe this likely international relations and security network ’ t an write out when you ’ re taking the drug once or a few times for curative effect .

Is there a quick/easy answer to how long psilocybin stays in your system or does that depnd on the dose and the form you take it in?

Half-life of psilocybin is about 2 to 6 hours, and effects wear off after about 5 to 6 hours, according to Andrew Penn, NP. Most people take it orally, though there have been some neuroimaging studies with IV psilocybin, but this is n’t how it ‘s normally administered .

What’s the best way to explain why psilocybin is illegal? Is it simply because the threshold for misuse remains high and it hasn’t been studied enough?

The Controlled Substance Act is a political, not a scientific law. The criteria for Schedule 1 is “ no therapeutic use and eminent potential for abuse, ” which is, of course, axiomatic, because how do you know if a drug has therapeutic use unless you study it, Andrew Penn, NP explains.

besides, note that alcohol, tobacco, and caffeine are some of the most widely-used substances in the earth and they are not scheduled substances and are only minimally regulated. ( Anyone can buy alcohol if they are more than 21 years old, for example. ) The Controlled Substance Act was part of the fall out of the 1960s psychedelic dionysia, and any fishy drugs got rounded up en masse, psilocybin being one of them .

With regards to microdosing, in Oregon where psilocybin is legal, how is a microdose administered?

Andrew Penn, NP says a microdose has no standard definition but is normally considered 1/10th of a standard dose. As a “ park acid ” of psilocybin might be 3 grams, that would be 300mg. It could be in a tea, tincture, or as a dry mushroom .
article Sources

1. 1. 1. Biography of R. Gordon Wasson: Harvard University Herbaria. R. Gordon Wasson (1898-1986) Archives. botlib.huh.harvard.edu/libraries/wasson/biog.html. Accessed February 16, 2021.
      2. Smoking Cessation with Psilocybin: American Journal of Drug and Alcohol Abuse. (2017) Long-term follow-up of psilocybin-facilitated smoking cessation. Available at https://pubmed.ncbi.nlm.nih.gov/27441452/. Accessed February 16, 2021.
      3. Major Depressive Disorder Remission and Psilocybin: JAMA Psychiatry (2020). Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder. Available at: jamanetwork.com/journals/jamapsychiatry/fullarticle/2772630. Accessed February 16, 2021.
      4. Decreased Depression in Cancer Patients. Journal of Psychopharmacology. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/. Accessed February 16, 2021.
      5. Psilocybin and Obsessive-Compulsive Disorder. ClinicalTrials.gov. (2017). Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. clinicaltrials.gov/ct2/show/NCT03356483 The Experience of Psilocybin: bioRxiv. (2020). How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans. Available at https://www.biorxiv.org/content/10.1101/2020.06.09.142802v1. Accessed February 16, 2021.
      6. Addictive Potential of Psilocybin: Neuropharmacology. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Available at: sciencedirect.com/science/article/pii/S0028390818302296?via%3Dihub. Accessed February 16, 2021.